Rashieda Gluck
Chief Tech/Sci/R&D Officer presso DIANTHUS THERAPEUTICS, INC.
Posizioni attive di Rashieda Gluck
Società | Posizione | Inizio | Fine |
---|---|---|---|
DIANTHUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 11/09/2023 | - |
Storia della carriera di Rashieda Gluck
Precedenti posizioni note di Rashieda Gluck
Società | Posizione | Inizio | Fine |
---|---|---|---|
AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01/05/2014 | 01/04/2022 |
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Chief Tech/Sci/R&D Officer | 01/12/2013 | 01/06/2015 |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Chief Tech/Sci/R&D Officer | 01/01/2008 | 01/07/2013 |
KANE BIOTECH INC. | Director/Board Member | 22/05/2018 | - |
Independent Dir/Board Member | 22/05/2018 | - | |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada. | Chief Tech/Sci/R&D Officer | - | - |
Formazione di Rashieda Gluck
University of British Columbia | Undergraduate Degree |
Statistiche
Distribuzione geografica
Canada | 6 |
Svizzera | 2 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 5 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 6 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
KANE BIOTECH INC. | Commercial Services |
AURINIA PHARMACEUTICALS INC. | Health Technology |
DIANTHUS THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada. | Health Technology |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Health Technology |
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
- Borsa valori
- Insiders
- Rashieda Gluck
- Esperienza